Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-28
DOI
10.1038/srep45236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
- (2016) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Insights into the in vitro Anticancer Effects of Diruthenium-1
- (2016) Aneta Koceva-Chyła et al. ChemMedChem
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Metal-based drugs that break the rules
- (2016) Claire S. Allardyce et al. DALTON TRANSACTIONS
- RuIIIComplexes for Anticancer Therapy: The Importance of Being Nucleolipidic
- (2016) Claudia Riccardi et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
- (2016) Lea S. Flocke et al. INVESTIGATIONAL NEW DRUGS
- Mitochondrial apoptosis: killing cancer using the enemy within
- (2015) J Lopez et al. BRITISH JOURNAL OF CANCER
- Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells
- (2015) A Grimaldi et al. CANCER BIOLOGY & THERAPY
- Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53
- (2015) Annapina Russo et al. CELL CYCLE
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies
- (2015) Giulia Palermo et al. ChemMedChem
- Interaction of anticancer Ru(iii) complexes with single stranded and duplex DNA model systems
- (2015) Domenica Musumeci et al. DALTON TRANSACTIONS
- Discoveries and controversies in BCL-2 protein-mediated apoptosis
- (2015) Janet H. Zheng et al. FEBS Journal
- Caspase-mediated crosstalk between autophagy and apoptosis: Mutual adjustment or matter of dominance
- (2015) ShrawanKumar Singh et al. Journal of Cancer Research and Therapeutics
- Cysteine Prevents the Reduction in Keratin Synthesis Induced by Iron Deficiency in Human Keratinocytes
- (2015) Maria Concetta Miniaci et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
- (2015) Ileana Dragutan et al. MOLECULES
- Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer
- (2015) D Merino et al. ONCOGENE
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex
- (2015) Giuseppe Vitiello et al. Journal of Materials Chemistry B
- Targeting autophagy in cancer management – strategies and developments
- (2015) Bulent Ozpolat et al. Cancer Management and Research
- Metal-based anticancer chemotherapeutic agents
- (2014) Nafees Muhammad et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation
- (2014) Daniele De Filippis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells
- (2014) Aliny Pereira Lima et al. PLoS One
- Metal-based drugs
- (2014) Ruth J. McQuitty SCIENCE PROGRESS
- Anticancer Cationic Ruthenium Nanovectors: From Rational Molecular Design to Cellular Uptake and Bioactivity
- (2013) Gaetano Mangiapia et al. BIOMACROMOLECULES
- A new design for nucleolipid-based Ru(iii) complexes as anticancer agents
- (2013) Daniela Montesarchio et al. DALTON TRANSACTIONS
- The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(ii) asymmetric complexes
- (2013) Chen Qian et al. Metallomics
- 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Promotes BHV-1 Infection in Mammalian Cells by Interfering with Iron Homeostasis Regulation
- (2013) Filomena Fiorito et al. PLoS One
- Cholesterol-Based Nucleolipid-Ruthenium Complex Stabilized by Lipid Aggregates for Antineoplastic Therapy
- (2012) Luca Simeone et al. BIOCONJUGATE CHEMISTRY
- Ruthenium-based complex nanocarriers for cancer therapy
- (2012) Gaetano Mangiapia et al. BIOMATERIALS
- Insights into the Mechanism of Action and Cellular Targets of Ruthenium Complexes from NMR Spectroscopy
- (2012) Federico Giannini et al. CHIMIA
- Novel metal-based anticancer drugs: a new challenge in drug delivery
- (2012) Anne-Laure Lainé et al. CURRENT OPINION IN PHARMACOLOGY
- Next-Generation Anticancer Metallodrugs
- (2012) Seiji Komeda et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC
- (2012) Gabriella Misso et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Regulation of the Autophagic Bcl-2/Beclin 1 Interaction
- (2012) Jean-Paul Decuypere et al. Cells
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
- (2011) Michael I. Webb et al. INORGANIC CHEMISTRY
- Platinum resistance in breast and ovarian cancer cell lines
- (2011) Niels Eckstein JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Nucleolipid nanovectors as molecular carriers for potential applications in drug delivery
- (2011) Luca Simeone et al. Molecular BioSystems
- Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
- (2010) J. Costa Pessoa et al. CURRENT MEDICINAL CHEMISTRY
- Challenges, controversies, breakthroughs
- (2010) Lisa Hutchinson Nature Reviews Clinical Oncology
- Aurora B expression in post-puberal testicular germ cell tumours
- (2009) Francesco Esposito et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started